Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.52
-6.3%
$0.56
$0.21
$0.83
$13.77M1.1236,709 shs66,431 shs
Nephros Inc. stock logo
NEPH
Nephros
$4.77
+2.8%
$4.05
$1.36
$5.00
$50.56M1.3259,464 shs46,001 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.43
+3.6%
$3.63
$3.03
$9.33
$56.39M1.3879,383 shs113,415 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.48
-0.3%
$0.36
$0.03
$1.00
$54.74M1.2674,785 shs3,165 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00%-12.69%-25.35%+43.04%+70.25%
Nephros Inc. stock logo
NEPH
Nephros
0.00%+7.19%+24.54%+16.91%+201.90%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+10.65%+6.19%-25.27%-45.47%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00%+6.68%+46.47%+71.44%+1,226.08%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.52
-6.3%
$0.56
$0.21
$0.83
$13.77M1.1236,709 shs66,431 shs
Nephros Inc. stock logo
NEPH
Nephros
$4.77
+2.8%
$4.05
$1.36
$5.00
$50.56M1.3259,464 shs46,001 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.43
+3.6%
$3.63
$3.03
$9.33
$56.39M1.3879,383 shs113,415 shs
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$0.48
-0.3%
$0.36
$0.03
$1.00
$54.74M1.2674,785 shs3,165 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biotricity, Inc. stock logo
BTCY
Biotricity
0.00%-12.69%-25.35%+43.04%+70.25%
Nephros Inc. stock logo
NEPH
Nephros
0.00%+7.19%+24.54%+16.91%+201.90%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+10.65%+6.19%-25.27%-45.47%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00%+6.68%+46.47%+71.44%+1,226.08%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
2.67
Moderate Buy$5.5015.30% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
2.20
Hold$8.00133.24% Upside
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BTCY, SRTS, NEPH, and TMDIF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/27/2025
Nephros Inc. stock logo
NEPH
Nephros
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/27/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/23/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHoldStrong Sell
8/12/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$12.00 ➝ $8.00
8/8/2025
Nephros Inc. stock logo
NEPH
Nephros
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$4.50 ➝ $6.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$13.00 ➝ $6.00
(Data available from 10/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M1.14N/AN/A($1.30) per share-0.40
Nephros Inc. stock logo
NEPH
Nephros
$14.16M3.57$0.02 per share238.37$0.81 per share5.89
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.35$0.43 per share7.94$3.41 per share1.01
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$17.63M3.11$24.00 per share0.02$1.05 per share0.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$0.21N/AN/A-80.42%N/A-188.47%11/13/2025 (Estimated)
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.1239.75N/A7.95%14.89%11.64%11/6/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M-$0.06N/A14.91N/A-2.26%-1.58%-1.41%11/13/2025 (Estimated)
Titan Medical Inc. stock logo
TMDIF
Titan Medical
$6.95M$0.05N/AN/AN/A-82.31%-51.47%N/A

Latest BTCY, SRTS, NEPH, and TMDIF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0250$0.02+$0.0450$0.02$3.60 million$4.40 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.41
4.14
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.14
5.79
Titan Medical Inc. stock logo
TMDIF
Titan Medical
N/A
3.73
3.73

Institutional Ownership

CompanyInstitutional Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.03%

Insider Ownership

CompanyInsider Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Titan Medical Inc. stock logo
TMDIF
Titan Medical
0.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4026.73 million22.08 millionOptionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
Titan Medical Inc. stock logo
TMDIF
Titan Medical
50114.04 million4.56 millionNot Optionable

Recent News About These Companies

Titan Announces Resignations of Directors
Proxy Deadline Thursday September 26, 2024
Titan Announces Q&A Session with Shareholders
Titan Medical | Morning Blend
Titan Medical Inc. (QTNA.SG)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.52 -0.03 (-6.31%)
As of 10/3/2025 03:43 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Nephros stock logo

Nephros NASDAQ:NEPH

$4.77 +0.13 (+2.80%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$4.77 0.00 (0.00%)
As of 10/3/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.43 +0.12 (+3.63%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$3.48 +0.05 (+1.60%)
As of 10/3/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Titan Medical stock logo

Titan Medical NASDAQ:TMDIF

$0.48 0.00 (-0.33%)
As of 10/3/2025

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.